Cyclin D1 and Bladder Cancer Recurrence
Author Information
Author(s): KY Shin, G Kong, WS Kim, TY Lee, YN Woo, JD Lee
Primary Institution: Hanyang University
Hypothesis
Is overexpression of cyclin D1 associated with poor prognosis in bladder cancer patients?
Conclusion
Overexpression of cyclin D1 is linked to early recurrence in superficial bladder cancers but not to overall survival in invasive cases.
Supporting Evidence
- Strong staining for cyclin D1 was observed in 25% of tumors.
- 64% of superficial tumors with strong cyclin D1 staining recurred within 12 months.
- Only 15% of superficial tumors with negative or weak staining recurred within 12 months.
Takeaway
If a bladder cancer has a lot of cyclin D1, it might come back quickly after treatment, but it doesn't mean the patient will live shorter.
Methodology
The study analyzed cyclin D1 expression in bladder cancer tissues using immunohistochemistry and reviewed medical records of 75 patients.
Limitations
The study's findings may not apply to all bladder cancer patients due to the specific characteristics of the sample.
Participant Demographics
Patients aged 30-83 years, average age 62, with transitional cell carcinoma.
Statistical Information
P-Value
p<0.01 for - vs ++; p<0.05 for + vs ++
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website